Joseph F. Woody

As chief executive officer and member of the board of directors, Joe Woody brings 20 years of healthcare leadership experience and proven success driving revenue growth and expertise in spearheading portfolio transformations.

Prior to joining the company in 2017, Joe served as chief executive officer and president of Acelity, where he was responsible for overseeing the development and commercialization of their innovative wound care and regenerative medicine business. He also served as global president, vascular therapies, for Covidien, creating their vascular division and leading the company’s acquisition and integration of ev3.

Before his time at Covidien, Joe served as Smith & Nephew’s global president, advanced wound management, and Alliance Imaging’s vice president, Pacific operations. He previously served as board director for Acelity, the Advanced Medical Technology Association (AdvaMed) and Systagenix Wound Management. He also served as Chair of AdvaMed’s Wound Healing and Tissue Regeneration Sector.

He holds a bachelor’s degree from California State University, Fullerton.